Ecsponent set to grow in 2016

Ecsponent has an established reputation for a forward-thinking approach to organic and acquisitive growth strategy and a strong future-based investment philosophy. Our CEO, Euné Engelbrecht, is confident that by seeking out value-enhancing acquisitions we will continue to reflect solid growth for our investors.   The latest notice to shareholders forecasts that for the year ended…

Details

Q&A about the effect of rising interest rates

Floris Slabbert, National Sales Manager of Ecsponent Financial Services, looks at some of the implications of rising interest rates Q: How do rising interest rates affect our economy? A: The recent interest rate increase was largely attributable to inflationary pressures in 2015. However, further increases are still likely due to additional inflationary pressures. These factors include…

Details

Biotech remains an increasingly bullish investment sector

Salveo Swiss Biotechnology and Cryo-Save form part of Ecsponent Limited’s investment strategy to acquire interests and develop technology businesses with high intellectual property and high barriers to entry.   Ecsponent’s investment in the biotech sector provides South African clients with international, industry leading stem cell storage within the biotechnology arena and is an example of…

Details